Page last updated: 2024-08-24

3-iodobenzylguanidine and Striatonigral Atrophy

3-iodobenzylguanidine has been researched along with Striatonigral Atrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvés, L; Artigas, C; Blesa, R; Camacho, V; Carrió, I; Duch, J; Estorch, M; Flotats, A; Gómez-Isla, T; Lleó, A; Marquié, M1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Striatonigral Atrophy

ArticleYear
Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Female; Heart Diseases; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Striatonigral Degeneration; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Tropanes

2011